Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury

Background: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the...

Full description

Bibliographic Details
Main Authors: Rong-Shuang Huang, Jiao-Jiao Zhou, Yu-Ying Feng, Min Shi, Fan Guo, Shen-Ju Gou, Stephen Salerno, Liang Ma, Ping Fu
Format: Article
Language:English
Published: Wolters Kluwer 2017-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2163;epage=2169;aulast=Huang
_version_ 1819238230588915712
author Rong-Shuang Huang
Jiao-Jiao Zhou
Yu-Ying Feng
Min Shi
Fan Guo
Shen-Ju Gou
Stephen Salerno
Liang Ma
Ping Fu
author_facet Rong-Shuang Huang
Jiao-Jiao Zhou
Yu-Ying Feng
Min Shi
Fan Guo
Shen-Ju Gou
Stephen Salerno
Liang Ma
Ping Fu
author_sort Rong-Shuang Huang
collection DOAJ
description Background: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the role of macrophage Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. Methods: C57BL/6 mice were injected with a 50% glycerin solution at bilateral back limbs to induce rhabdomyolysis, and CLI-095 or pyrrolidine dithiocarbamate (PDTC) was intraperitoneally injected at 0.5 h before molding. Serum creatinine levels, creatine kinase, the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, and hematoxylin and eosin stainings of kidney tissues were tested. The infiltration of macrophage, mRNA levels, and protein expression of TLR4 and NF-κB were investigated by immunofluorescence double-staining techniques, reverse transcriptase-quantitative polymerase chain reaction, and Western blotting, respectively. In vitro, macrophage RAW264.7 was stimulated by ferrous myoglobin; the cytokines, TLR4 and NF-κB expressions were also detected. Results: In an in vivo study, using CLI-095 or PDTC to block TLR4/NF-κB, functional and histologic results showed that the inhibition of TLR4 or NF-κB alleviated glycerol-induced renal damages (P < 0.01). CLI-095 or PDTC administration suppressed proinflammatory cytokine (TNF-α, IL-6, and IL-1β) production and macrophage infiltration into the kidney (P < 0.01). Moreover, in an in vitro study, CLI-095 or PDTC suppressed myoglobin-induced expression of TLR4, NF-κB, and proinflammatory cytokine levels in macrophage RAW264.7 cells (P < 0.01). Conclusion: The pharmacological inhibition of TLR4/NF-κB exhibited protective effects on rhabdomyolysis-induced AKI by the regulation of proinflammatory cytokine production and macrophage infiltration.
first_indexed 2024-12-23T13:32:55Z
format Article
id doaj.art-7a56a93b46e843089e0e45f2bc92a6a2
institution Directory Open Access Journal
issn 0366-6999
language English
last_indexed 2024-12-23T13:32:55Z
publishDate 2017-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-7a56a93b46e843089e0e45f2bc92a6a22022-12-21T17:45:07ZengWolters KluwerChinese Medical Journal0366-69992017-01-01130182163216910.4103/0366-6999.213406Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney InjuryRong-Shuang HuangJiao-Jiao ZhouYu-Ying FengMin ShiFan GuoShen-Ju GouStephen SalernoLiang MaPing FuBackground: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the role of macrophage Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. Methods: C57BL/6 mice were injected with a 50% glycerin solution at bilateral back limbs to induce rhabdomyolysis, and CLI-095 or pyrrolidine dithiocarbamate (PDTC) was intraperitoneally injected at 0.5 h before molding. Serum creatinine levels, creatine kinase, the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, and hematoxylin and eosin stainings of kidney tissues were tested. The infiltration of macrophage, mRNA levels, and protein expression of TLR4 and NF-κB were investigated by immunofluorescence double-staining techniques, reverse transcriptase-quantitative polymerase chain reaction, and Western blotting, respectively. In vitro, macrophage RAW264.7 was stimulated by ferrous myoglobin; the cytokines, TLR4 and NF-κB expressions were also detected. Results: In an in vivo study, using CLI-095 or PDTC to block TLR4/NF-κB, functional and histologic results showed that the inhibition of TLR4 or NF-κB alleviated glycerol-induced renal damages (P < 0.01). CLI-095 or PDTC administration suppressed proinflammatory cytokine (TNF-α, IL-6, and IL-1β) production and macrophage infiltration into the kidney (P < 0.01). Moreover, in an in vitro study, CLI-095 or PDTC suppressed myoglobin-induced expression of TLR4, NF-κB, and proinflammatory cytokine levels in macrophage RAW264.7 cells (P < 0.01). Conclusion: The pharmacological inhibition of TLR4/NF-κB exhibited protective effects on rhabdomyolysis-induced AKI by the regulation of proinflammatory cytokine production and macrophage infiltration.http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2163;epage=2169;aulast=HuangAcute Kidney Injury; Macrophages; Rhabdomyolysis; Toll-Like Receptor 4; NF-kappa B
spellingShingle Rong-Shuang Huang
Jiao-Jiao Zhou
Yu-Ying Feng
Min Shi
Fan Guo
Shen-Ju Gou
Stephen Salerno
Liang Ma
Ping Fu
Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
Chinese Medical Journal
Acute Kidney Injury; Macrophages; Rhabdomyolysis; Toll-Like Receptor 4; NF-kappa B
title Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_full Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_fullStr Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_full_unstemmed Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_short Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_sort pharmacological inhibition of macrophage toll like receptor 4 nuclear factor kappa b alleviates rhabdomyolysis induced acute kidney injury
topic Acute Kidney Injury; Macrophages; Rhabdomyolysis; Toll-Like Receptor 4; NF-kappa B
url http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2163;epage=2169;aulast=Huang
work_keys_str_mv AT rongshuanghuang pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT jiaojiaozhou pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT yuyingfeng pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT minshi pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT fanguo pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT shenjugou pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT stephensalerno pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT liangma pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT pingfu pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury